Phosphoproteome analysis demonstrates the potential role of THRAP3 phosphorylation in androgen-independent prostate cancer cell growth.
about
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate CancerMetastatic triple-negative breast cancer patient with TP53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events.Functional Analysis of Human Hub Proteins and Their Interactors Involved in the Intrinsic Disorder-Enriched Interactions.Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives.THRAP3 interacts with and inhibits the transcriptional activity of SOX9 during chondrogenesis.Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer.
P2860
Phosphoproteome analysis demonstrates the potential role of THRAP3 phosphorylation in androgen-independent prostate cancer cell growth.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Phosphoproteome analysis demon ...... t prostate cancer cell growth.
@en
type
label
Phosphoproteome analysis demon ...... t prostate cancer cell growth.
@en
prefLabel
Phosphoproteome analysis demon ...... t prostate cancer cell growth.
@en
P2093
P2860
P356
P1433
P1476
Phosphoproteome analysis demon ...... t prostate cancer cell growth.
@en
P2093
Hiroji Uemura
Hisashi Hirano
Hitoshi Ishiguro
Noriaki Arakawa
Tosifusa Toda
Yoshinobu Kubota
P2860
P304
P356
10.1002/PMIC.201500365
P577
2016-02-03T00:00:00Z